Business Context and Reporting Period
Pilgrim's Pride Corporation (PPC) is a vertically integrated producer, processor, and distributor of fresh, frozen, and value-added chicken and pork products. The company operates in three reportable segments: U.S., Europe, and Mexico. JBS S.A. beneficially owns approximately 82.42% of the outstanding common stock. This filing covers the fiscal year ended December 29, 2024, which was a 52-week fiscal year (compared to a 53-week fiscal year in 2023).
Key Financial Metrics
| Metric | 2024 (in millions) | 2023 (in millions) |
|---|---|---|
| Net Sales | $17,878.3 | $17,362.2 |
| Gross Profit | $2,312.8 | $1,118.4 |
| Operating Income | $1,506.1 | $522.3 |
| Net Income (Attributable to PPC) | $1,086.4 | $321.6 |
| Diluted EPS | $4.57 | $1.36 |
| Operating Margin | 8.4% | 3.0% |
| Cash from Operating Activities | $1,990.1 | $677.9 |
| EBITDA | $1,934.4 | $951.7 |
| Adjusted EBITDA | $2,213.9 | $1,034.2 |
| Total Debt (Unsecured) | $3,256.3 | $3,379.2 |
| Cash and Cash Equivalents | $2,040.8 | $697.7 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3.0% to $17.9 billion, driven primarily by a 6.0% increase in U.S. sales due to higher commodity pricing, partially offset by declines in Europe and Mexico.
- Profitability Surge: Operating income more than doubled, increasing 188.4% to $1.5 billion. Gross profit rose 106.8% to $2.3 billion, reflecting lower feed ingredient costs (corn and soybean meal) and improved operational efficiencies.
- Segment Performance:
- U.S.: Operating income increased 365.9% to $1.1 billion, driven by higher sales prices and lower feed costs.
- Europe: Operating income increased 32.4% to $170 million despite restructuring charges of $93.4 million.
- Mexico: Operating income increased 43.7% to $223 million, aided by favorable currency remeasurement and lower commodity costs.
- Interest Expense: Net interest expense decreased 46.9% to $88.5 million due to higher interest income on cash balances and gains on debt extinguishment.
Guidance, Outlook, and Risks
- Capital Expenditures: The company anticipates spending between $450 million and $500 million on property, plant, and equipment in 2025 to support growth and efficiency projects.
- Restructuring: Ongoing restructuring initiatives in the Europe segment are expected to continue through 2025, with total estimated costs of $186.6 million. $93.4 million was incurred in 2024.
- Debt Management: The company repurchased $164.3 million of senior notes in 2024, realizing a gross gain of $13.8 million. A bond repurchase program authorizing up to $200 million remains active.
- Key Risks:
- Commodity Prices: Earnings remain sensitive to feed ingredient costs (corn, soybean meal, wheat) and market prices for chicken and pork.
- Disease Outbreaks: Risks include avian influenza (HPAI/LPAI) and African swine fever, which could disrupt operations and demand.
- Legal Proceedings: Significant litigation includes antitrust settlements (Broiler Chicken Antitrust Litigation) totaling $195.5 million for certified classes, with additional expenses recognized for "opt-out" plaintiffs. A $100 million settlement for the Broiler Chicken Grower Litigation was paid in October 2024.
- Regulatory: Compliance with the EU Deforestation Regulation (EUDR) and GDPR may increase costs. The company also faces tax audits in Mexico and the U.K.
Investor Verification Checklist
- Feed Cost Volatility: Verify current corn and soybean meal prices against the 2024 average to assess margin sustainability.
- Antitrust Litigation Status: Monitor the resolution of "Broiler Opt Out" claims and the outcome of the pending Mexican tax assessment ($269.5 million) regarding the Tyson de Mexico acquisition.
- Europe Restructuring Progress: Track the execution of facility closures and cost savings in the Europe segment to ensure projected benefits are realized.
- Debt Covenants: Confirm continued compliance with financial covenants under the U.S., Europe, and Mexico credit facilities, particularly given the high leverage ratio.
- Avian Influenza Impact: Assess any new outbreaks in the U.S., Europe, or Mexico that could impact production volumes or export markets.